Global Drug Repositioning Market Research Report 2023(Status and Outlook)
Report Overview
Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
The Global Drug Repositioning Market Size was estimated at USD 26270.00 million in 2022 and is projected to reach USD 36231.54 million by 2029, exhibiting a CAGR of 4.70% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Drug Repositioning market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug Repositioning Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug Repositioning market in any manner.
Global Drug Repositioning Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Teva
Novartis
Mylan
Johnson & Johnson
Pfizer
Bausch Health
GSK
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Market Segmentation (by Type)
Generic Drugs
Clinical Trial Failed Drugs
Market Segmentation (by Application)
Machinery
Electronic
Furniture
Automotive
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Drug Repositioning Market
Overview of the regional outlook of the Drug Repositioning Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Drug Repositioning
- 1.2 Key Market Segments
- 1.2.1 Drug Repositioning Segment by Type
- 1.2.2 Drug Repositioning Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Drug Repositioning Market Overview
- 2.1 Global Drug Repositioning Market Size (M USD) Estimates and Forecasts (2018-2029)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Drug Repositioning Market Competitive Landscape
- 3.1 Global Drug Repositioning Revenue Market Share by Manufacturers (2018-2023)
- 3.2 Drug Repositioning Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Manufacturers Drug Repositioning Sales Sites, Area Served, Service Type
- 3.4 Drug Repositioning Market Competitive Situation and Trends
- 3.4.1 Drug Repositioning Market Concentration Rate
- 3.4.2 Global 5 and 10 Largest Drug Repositioning Players Market Share by Revenue
- 3.4.3 Mergers & Acquisitions, Expansion
- 4 Drug Repositioning Value Chain Analysis
- 4.1 Drug Repositioning Value Chain Analysis
- 4.2 Midstream Market Analysis
- 4.3 Downstream Customer Analysis
- 5 The Development and Dynamics of Drug Repositioning Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 Mergers & Acquisitions
- 5.5.2 Expansions
- 5.5.3 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Drug Repositioning Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Drug Repositioning Market Size Market Share by Type (2018-2023)
- 6.3 Global Drug Repositioning Sales Growth Rate by Type (2019-2023)
- 7 Drug Repositioning Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Drug Repositioning Market Size (M USD) by Application (2018-2023)
- 7.3 Global Drug Repositioning Sales Growth Rate by Application (2019-2023)
- 8 Drug Repositioning Market Segmentation by Region
- 8.1 Global Drug Repositioning Market Size by Region
- 8.1.1 Global Drug Repositioning Market Size by Region
- 8.1.2 Global Drug Repositioning Market Share by Region
- 8.2 North America
- 8.2.1 North America Drug Repositioning Market Size by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Drug Repositioning Market Size by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Drug Repositioning Market Size by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Drug Repositioning Market Size by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Drug Repositioning Market Size by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Teva
- 9.1.1 Teva Drug Repositioning Basic Information
- 9.1.2 Teva Drug Repositioning Product Overview
- 9.1.3 Teva Drug Repositioning Product Market Performance
- 9.1.4 Teva Business Overview
- 9.1.5 Teva Drug Repositioning SWOT Analysis
- 9.1.6 Teva Recent Developments
- 9.2 Novartis
- 9.2.1 Novartis Drug Repositioning Basic Information
- 9.2.2 Novartis Drug Repositioning Product Overview
- 9.2.3 Novartis Drug Repositioning Product Market Performance
- 9.2.4 Novartis Business Overview
- 9.2.5 Novartis Drug Repositioning SWOT Analysis
- 9.2.6 Novartis Recent Developments
- 9.3 Mylan
- 9.3.1 Mylan Drug Repositioning Basic Information
- 9.3.2 Mylan Drug Repositioning Product Overview
- 9.3.3 Mylan Drug Repositioning Product Market Performance
- 9.3.4 Mylan Business Overview
- 9.3.5 Mylan Drug Repositioning SWOT Analysis
- 9.3.6 Mylan Recent Developments
- 9.4 Johnson andamp; Johnson
- 9.4.1 Johnson andamp; Johnson Drug Repositioning Basic Information
- 9.4.2 Johnson andamp; Johnson Drug Repositioning Product Overview
- 9.4.3 Johnson andamp; Johnson Drug Repositioning Product Market Performance
- 9.4.4 Johnson andamp; Johnson Business Overview
- 9.4.5 Johnson andamp; Johnson Recent Developments
- 9.5 Pfizer
- 9.5.1 Pfizer Drug Repositioning Basic Information
- 9.5.2 Pfizer Drug Repositioning Product Overview
- 9.5.3 Pfizer Drug Repositioning Product Market Performance
- 9.5.4 Pfizer Business Overview
- 9.5.5 Pfizer Recent Developments
- 9.6 Bausch Health
- 9.6.1 Bausch Health Drug Repositioning Basic Information
- 9.6.2 Bausch Health Drug Repositioning Product Overview
- 9.6.3 Bausch Health Drug Repositioning Product Market Performance
- 9.6.4 Bausch Health Business Overview
- 9.6.5 Bausch Health Recent Developments
- 9.7 GSK
- 9.7.1 GSK Drug Repositioning Basic Information
- 9.7.2 GSK Drug Repositioning Product Overview
- 9.7.3 GSK Drug Repositioning Product Market Performance
- 9.7.4 GSK Business Overview
- 9.7.5 GSK Recent Developments
- 9.8 ChemRar Group
- 9.8.1 ChemRar Group Drug Repositioning Basic Information
- 9.8.2 ChemRar Group Drug Repositioning Product Overview
- 9.8.3 ChemRar Group Drug Repositioning Product Market Performance
- 9.8.4 ChemRar Group Business Overview
- 9.8.5 ChemRar Group Recent Developments
- 9.9 Glenmark
- 9.9.1 Glenmark Drug Repositioning Basic Information
- 9.9.2 Glenmark Drug Repositioning Product Overview
- 9.9.3 Glenmark Drug Repositioning Product Market Performance
- 9.9.4 Glenmark Business Overview
- 9.9.5 Glenmark Recent Developments
- 9.10 Fujifilm
- 9.10.1 Fujifilm Drug Repositioning Basic Information
- 9.10.2 Fujifilm Drug Repositioning Product Overview
- 9.10.3 Fujifilm Drug Repositioning Product Market Performance
- 9.10.4 Fujifilm Business Overview
- 9.10.5 Fujifilm Recent Developments
- 9.11 Dr. Reddy
- 9.11.1 Dr. Reddy Drug Repositioning Basic Information
- 9.11.2 Dr. Reddy Drug Repositioning Product Overview
- 9.11.3 Dr. Reddy Drug Repositioning Product Market Performance
- 9.11.4 Dr. Reddy Business Overview
- 9.11.5 Dr. Reddy Recent Developments
- 9.12 R-Pharma
- 9.12.1 R-Pharma Drug Repositioning Basic Information
- 9.12.2 R-Pharma Drug Repositioning Product Overview
- 9.12.3 R-Pharma Drug Repositioning Product Market Performance
- 9.12.4 R-Pharma Business Overview
- 9.12.5 R-Pharma Recent Developments
- 10 Drug Repositioning Regional Market Forecast
- 10.1 Global Drug Repositioning Market Size Forecast
- 10.2 Global Drug Repositioning Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Drug Repositioning Market Size Forecast by Country
- 10.2.3 Asia Pacific Drug Repositioning Market Size Forecast by Region
- 10.2.4 South America Drug Repositioning Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Drug Repositioning by Country
- 11 Forecast Market by Type and by Application (2024-2029)
- 11.1 Global Drug Repositioning Market Forecast by Type (2024-2029)
- 11.2 Global Drug Repositioning Market Forecast by Application (2024-2029)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook